Delta-Fly Pharma, Inc.

Delta-Fly Pharma, Inc.verified

4598.T

Price:

$496

Market Cap:

$5.70B

Delta-Fly Pharma, Inc. develops anticancer drugs. It develops DFP-10917 that is in phase III clinical trial in the United States and phase I trial in Japan for the treatment of relapsed/refractory acute myeloid leukemia; DFP-14323, which is in phase III clinical trial to treat lung cancer; DFP-17729 that is in phase I/II clinical trials for the treatment of solid cancer; DFP-11207, which has completed phase I clinical trial to treat pancreatic cancer; DFP-14927 that is in phase I for the treatment of hematologic cancer; and DFP-10825, which is in preclinical trial to treat gastric/ovarian cancer. Delta-Fly Pharma, Inc. was incorporated in 2010 and is headquartered in Tokushima, Japan.

Industry

Biotechnology

IPO Date

2018-10-12

Stock Exchange

JPX

Ticker

4598.T

The Current Ratio as of December 2025 (TTM) for Delta-Fly Pharma, Inc. (4598.T) is 3.06

According to Delta-Fly Pharma, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 3.06. This represents a change of -27.93% compared to the average of 4.25 of the last 4 quarters.

Delta-Fly Pharma, Inc. (4598.T) Historical Current Ratio (quarterly & annually)

How has 4598.T Current Ratio performed in the past?

The mean historical Current Ratio of Delta-Fly Pharma, Inc. over the last ten years is 16.88. The current 3.06 Current Ratio has changed 1.71% with respect to the historical average. Over the past ten years (40 quarters), 4598.T's Current Ratio was at its highest in in the December 2018 quarter at 94.54. The Current Ratio was at its lowest in in the December 2022 quarter at -1.00.

Quarterly (TTM)
Annual

Average

16.88

Median

7.49

Minimum

-0.05

Maximum

61.98

Delta-Fly Pharma, Inc. (4598.T) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Delta-Fly Pharma, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 448.23%

Maximum Annual Current Ratio = 61.98

Minimum Annual Increase = -47776.91%

Minimum Annual Current Ratio = -0.05

Quarterly (TTM)
Annual
YearCurrent RatioChange
20252.52-57.51%
20245.93-20.80%
20237.49-46.66%
202214.05-45.24%
202125.65-47776.91%
2020-0.05-100.09%
201961.98113.08%
201829.09448.23%

Delta-Fly Pharma, Inc. (4598.T) Average Current Ratio

How has 4598.T Current Ratio performed in the past?

The current Current Ratio of Delta-Fly Pharma, Inc. (4598.T) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

5.32

5-year avg

11.13

10-year avg

16.88

Delta-Fly Pharma, Inc. (4598.T) Current Ratio vs. Peers

How is 4598.T’s Current Ratio compared to its peers?

Delta-Fly Pharma, Inc.’s Current Ratio is less than D. Western Therapeutics Institute, Inc. (9.15), less than Carna Biosciences, Inc. (9.18), less than FunPep Company Limited (4.65), less than Ribomic Inc. (25.23), less than Soiken Holdings Inc. (8.72), less than Kubota Pharmaceutical Holdings Co., Ltd. (18.38), less than Immuno-Biological Laboratories Co., Ltd. (4.83), less than PRISM BioLab Co.,LTD (8.21), greater than Trans Genic Inc. (1.92), less than Kringle Pharma, Inc. (18.80),

Build a custom stock screener for Delta-Fly Pharma, Inc. (4598.T) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Delta-Fly Pharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Delta-Fly Pharma, Inc. (4598.T) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Delta-Fly Pharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Delta-Fly Pharma, Inc.'s Current Ratio?

How is the Current Ratio calculated for Delta-Fly Pharma, Inc. (4598.T)?

What is the highest Current Ratio for Delta-Fly Pharma, Inc. (4598.T)?

What is the 3-year average Current Ratio for Delta-Fly Pharma, Inc. (4598.T)?

What is the 5-year average Current Ratio for Delta-Fly Pharma, Inc. (4598.T)?

How does the current Current Ratio for Delta-Fly Pharma, Inc. (4598.T) compare to its historical average?